OS Therapies Incorporated
OSTX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $3 | $3 | $3 | $2 |
| G&A Expenses | $0 | $1 | $1 | $2 |
| SG&A Expenses | $4 | $1 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $7 | $4 | $4 | $4 |
| Operating Income | -$7 | -$4 | -$4 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$3 | -$2 | -$3 |
| Pre-Tax Income | -$9 | -$8 | -$6 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$8 | -$6 | -$7 |
| % Margin | – | – | – | – |
| EPS | -0.52 | -0.39 | -0.28 | -0.33 |
| % Growth | -33.3% | -39.3% | 15.2% | – |
| EPS Diluted | -0.52 | -0.39 | -0.28 | -0.33 |
| Weighted Avg Shares Out | 21 | 20 | 23 | 23 |
| Weighted Avg Shares Out Dil | 21 | 20 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $3 | $2 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$4 | -$4 | -$5 |
| % Margin | – | – | – | – |